We at Astria listen to patient communities to better understand their needs.
We are charting a new path for people living with allergic and immunologic diseases - one that envisions an opportunity for a better quality of life with safe and effective long-acting preventative therapies.
Learn more about navenibart (STAR-0215), in development for the potential preventative treatment of hereditary angioedema.
Learn more about STAR-0310, in development for the potential treatment of atopic dermatitis.
